Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs LFSC overlap: 16% of top holdings shared

Bottom line

How much do XBI and LFSC overlap?

16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 5.8% of XBI's assets and 26.4% of LFSC's. They are substantially different portfolios, so owning both adds real diversification.

XBI holds far more positions (161 vs 40), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XBILFSC
Weight overlap (top 25)16%
Shared holdings5
Weight in shared holdings5.8%26.4%
Total positions16140
Expense ratio0.35%0.54%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings XBI and LFSC have in common

Holding% of XBI% of LFSCOverlap
Dianthus Therapeutics Inc1.18%3.09%1.18%
Cytokinetics Inc1.18%3.16%1.18%
Mirum Pharmaceuticals Inc1.16%4.92%1.16%
Cogent Biosciences Inc1.14%7.53%1.14%
Travere Therapeutics Inc1.13%7.67%1.13%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%
  11. Rhythm Pharmaceuticals Inc — 1.20%
  12. CG oncology Inc — 1.20%
  13. SELLAS Life Sciences Group Inc — 1.19%
  14. Vaxcyte Inc — 1.19%
  15. Natera Inc — 1.16%

Only in LFSC

  1. LivaNova PLC — 7.11%
  2. Spyre Therapeutics Inc — 6.41%
  3. Guardant Health Inc — 5.52%
  4. Corcept Therapeutics Inc — 4.79%
  5. United Therapeutics Corp — 4.16%
  6. VeraDermics Inc — 3.42%
  7. Savara Inc — 3.22%
  8. Nektar Therapeutics — 3.14%
  9. Trevi Therapeutics Inc — 3.12%
  10. Axsome Therapeutics Inc — 2.84%
  11. Billiontoone Inc — 2.73%
  12. TransMedics Group Inc — 2.68%
  13. Viridian Therapeutics Inc — 2.24%
  14. ICU Medical Inc — 2.09%
  15. Corvus Pharmaceuticals Inc — 1.95%

Asset mix

Asset typeXBILFSC
Stocks99.9%100.0%
Cash & short-term funds5.9%—
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryXBILFSC
US100.8%92.0%
GB—7.1%
IE1.2%—
BM1.2%—
NL1.0%—
CH1.0%—
SG—1.0%
VG0.5%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do XBI and LFSC overlap?
About 16% by weight. 5 securities appear in both funds' top 25 holdings; they make up 5.8% of XBI's assets and 26.4% of LFSC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and LFSC have in common?
The largest shared holdings are Dianthus Therapeutics Inc, Cytokinetics Inc, Mirum Pharmaceuticals Inc, Cogent Biosciences Inc, Travere Therapeutics Inc.
Should I own both XBI and LFSC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or LFSC?
XBI is broader, with 161 positions versus 40 for LFSC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.